Showing results (1771-1780 of 1,853) with videos related to
Sort By:
Pageof 186
Journal of Managed Care & Specialty Pharmacy|October 29, 2021
Cardiovascular risk prediction model and stratification in patients with type 2 diabetes enrolled in a Medicare Advantage planEleanor O Caplan, Jennifer Hayden, Pratik Pimple, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2021
Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United StatesAnuja Chatterjee, Sheila Shapouri, Beenish S Manzoor, et al.Journal of Managed Care & Specialty Pharmacy|November 2, 2021
Health spending expenditures for commercial plans are predominantly concentrated among a small population of high-intensity consumers across settings of careMichael Ciarametaro, Michael Kleinrock, Allen Campbell, et al.Journal of Managed Care & Specialty Pharmacy|November 2, 2021
The budget impact of adding pralsetinib to a US health plan formulary for treatment of non-small cell lung cancer and thyroid cancer with RET alterationsSteve Duff, Francesca Bargiacchi, Chelsea Norregaard, et al.Journal of Managed Care & Specialty Pharmacy|April 8, 2022
The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018Carrie McAdam-Marx, Natalia Ruiz-Negron, Jane M Sullivan, et al.Journal of Managed Care & Specialty Pharmacy|May 1, 2023
Geographic atrophy: Mechanism of disease, pathophysiology, and role of the complement systemSophie J Bakri, Meryem Bektas, Darcie Sharp, et al.Journal of Managed Care & Specialty Pharmacy|May 3, 2023
Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterolSanjay Sethi, Swetha R Palli, Lindsay G S Bengtson, et al.Journal of Managed Care & Specialty Pharmacy|May 3, 2023
Financial burden associated with discordance to intravenous iron therapies in US patients with iron deficiency anemiaMichael K Polson, Huzefa Bahrain, Jonathan F Ogden, et al.Journal of Managed Care & Specialty Pharmacy|May 3, 2023
Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United StatesJoseph E Biskupiak, Mafalda Ramos, Carol J Levy, et al.Journal of Managed Care & Specialty Pharmacy|March 26, 2021
Verifying the value of existing frameworks for formulary review at a large academic health system: assessing inter-rater reliabilityBrittany Lee Karas, Mary Frances Picone, Shannon Werner, et al.Pageof 186